HanyElmariahMD

PubMed

• Mismatched donor allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide achieves comparable outcomes between racially and ethnically diver...
  Teresa Caprice, Wenyi Fan, Jongphil Kim, Rawan Faramand, Asmita Mishra, Lia Perez, Farhad Khimani, Aleksandr Lazar-Yan, Jose L Ochoa-Bayona, Hien Liu, Michael D Jain, ...> ;American Journal of Hematology. 2024 Mar 28
• Hypomethylating Agents and Venetoclax for Acute Myeloid Leukemia Relapsed After Hematopoietic Stem Cell Transplant.
  Ionescu, F., David, J., Ravichandran, A., Sallman, D., Sweet, K., Komrokji, R., Chan, O., Kuykendall, A., Padron, E., Faramand, R., Bejanyan, N., Khimani, F., Elmariah...> ;Clinical Lymphoma, Myeloma & Leukemia. 2024 Feb 12
• Association between,andgenotype and tacrolimus treatment outcomes among allogeneic HSCT patients.
  Ho, T., Perkins, J., Gonzalez, R., Hicks, J., Martinez, R., Duranceau, K., North, B., Kim, J., Teer, J., Yao, J., Yoder, S., Nishihori, T., Bejanyan, N., Pidala, J., E...> ;Pharmacogenomics. 2024 Jan 1
• Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Pos...
  Elmariah, H., Otoukesh, S., Kumar, A., Ali, H., Arslan, S., Shouse, G., Pourhassan, H., Nishihori, T., Faramand, R., Mishra, A., Khimani, F., Fernandez, H., Lazaryan, ...> ;Transplantation and Cellular Therapy. 2024 Feb 1
• 46 citations
  Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
  Javier Bolaños-Meade, Mehdi Hamadani, Juan Wu, Monzr M Al Malki, Michael J Martens, Lyndsey Runaas, Hany Elmariah, Andrew R Rezvani, Mahasweta Gooptu, Karilyn T Larkin...> ;The New England Journal of Medicine. 2023 Jun 22
• 2 citations
  Cardiac events after standard of care idecabtagene vicleucel for relapsed and refractory multiple myeloma.
  Dae Hyun Lee, Abhishek Kumar, Turab Mohammed, Lauren C Peres, Melissa Alsina, Christina Bachmeier, Brandon J Blue, Jason Brayer, Sanjay Chandrasekhar, Ariel Grajales C...> ;Blood Advances. 2023 Aug 22
• 1 citations
  Trends and in-hospital cardiac complications in patients with atrial fibrillation undergoing allogeneic stem cell transplant: A National Inpatient Sample analysis (200...
  Mohammad Ammad Ud Din, Medhat Chowdhury, Moazzam Shahzad, Salman Zahid, Hania Liaqat, Muhammad Osama, Hany Elmariah> ;European Journal of Haematology. 2023 Jun 1
• Haploidentical Donor Blood or Marrow Transplantation for Myelodysplastic/Myeloproliferative Overlap Neoplasms: Results from a North American Collaboration.
  Tania Jain, Hua-Ling Tsai, Hany Elmariah, Pankit Vachhani, Theodoros Karantanos, Sarah Wall, Lukasz Gondek, Asad Bashey, Alla Keyzner, Roni Tamari, Michael Grunwald, S...> ;Research Square. 2023 Mar 21
• 3 citations
  NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.
  Ayman Saad, Alison Loren, Javier Bolaños-Meade, George Chen, Daniel Couriel, Antonio Di Stasi, Areej El-Jawahri, Hany Elmariah, Sherif Farag, Krishna Gundabolu, Jonath...> ;Journal of the National Comprehensive Cancer Network. 2023 Feb 1
• 5 citations
  Outcomes of CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Patients with Reduced Renal Function Including Dialysis.
  Anthony C Wood, Ariel Perez Perez, Brian Arciola, Kedar Patel, Grace Johnson, Elizabeth DiMaggio, Christina A Bachmeier, Kayla Reid, Salvatore Carallo, Melanie H Varga...> ;Transplantation and Cellular Therapy. 2022 Dec 1
• 17 citations
  Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
  Saygin, C., Roloff, G., Hahn, C., Chhetri, R., Gill, S., Elmariah, H., Talati, C., Nunley, E., Gao, G., Kim, A., Bishop, M., Kosuri, S., Das, S., Singhal, D., Venugopa...> ;Blood Advances. 2023 Feb 28
• 23 citations
  Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma.
  Jennifer M Logue, Lauren C Peres, Hamza Hashmi, Christelle M Colin-Leitzinger, Alexandria M Shrewsbury, Hitomi Hosoya, Rebecca M Gonzalez, Christina Copponex, Krista H...> ;Blood Advances. 2022 Dec 27
• 11 citations
  Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibr...
  Tania Jain, Hua-Ling Tsai, Amy E DeZern, Lukasz P Gondek, Hany Elmariah, Javier Bolaños-Meade, Leonido Luznik, Ephraim Fuchs, Richard Ambinder, Douglas E Gladstone, Ph...> ;Transplantation and Cellular Therapy. 2022 May 1
• 2 citations
  Outcomes Following Intolerance to Tacrolimus/Sirolimus Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation.
  Abu-Sayeef Mirza, Ankita Tandon, Dakota Jenneman, Shu Cao, Thomas Brimer, Ambuj Kumar, Michelle Kidd, Farhad Khimani, Rawan Faramand, Asmita Mishra, Hien Liu, Taiga Ni...> ;Transplantation and Cellular Therapy. 2022 Apr 1
• 3 citations
  Commentary: Target CD34 Cell Dose for Allogeneic Hematopoietic Cell Transplantation: Can We Finally Agree?
  Hany Elmariah> ;Transplantation and Cellular Therapy. 2022 Feb 1
• 9 citations
  Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical HCT with Post-Transplant Cyclophosphamide: CRS post haploidentical HCT with PTCy.
  Salman Otoukesh, Hany Elmariah, Dongyun Yang, Mary C. Clark, Madiha Siraj, Haris Ali, Krishnakar Mogili, Shukaib Arslan, Taiga Nishihori, Ryotaro Nakamura, Joseph Pida...> ;Transplantation and Cellular Therapy. 2021 Nov 26
• 12 citations
  Umbilical cord blood or HLA-haploidentical transplantation: Real world outcomes vs randomized trial outcomes
  Paul O'Donnell, Claudio G. Brunstein, Ephraim J. Fuchs, Mei-Jie Zhang, Mariam Allbee Johnson, Joseph H. Antin, Eric S. Leifer, Hany Elmariah, Michael R. Grunwald, Hamz...> ;Transplantation and Cellular Therapy. 2021 Nov 10
• 15 citations
  Increased Infections and Delayed CD4+ T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophyla...
  Farhad Khimani, Peter Ranspach, Hany Elmariah, Jongphil Kim, Junmin Whiting, Taiga Nishihori, Frederick L. Locke, Ariel Perez Perez, Erin Dean, Asmita Mishra, Lia Pere...> ;Transplantation and Cellular Therapy. 2021 Nov 1
• 23 citations
  Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study
  Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, Mich...> ;Leukemia. 2021 Oct 18
• 3 citations
  Phase 2 multicenter trial of ofatumumab and prednisone as initial therapy of chronic graft-vs-host disease
  Aleksandr Lazaryan, Stephanie J. Lee, Mukta Arora, Jongphil Kim, Brian C. Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A. Kharfan-Dabaja, ...> ;Blood Advances. 2021 Oct 14
• 77 citations
  Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead.
  Kedar Kirtane, Hany Elmariah, Christine H. Chung, Daniel Abate-Daga> ;Journal for Immunotherapy of Cancer. 2021 Jul 1
• 14 citations
  Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell ...
  Farhad Khimani, Mudit Dutta, Rawan Faramand, Taiga Nishihori, Ariel Perez Perez, Erin Dean, Michael Nieder, Lia Perez, Asmita Mishra, Hany Elmariah, Marco L. Davila, L...> ;Transplantation and Cellular Therapy. 2021 Jul 1
• 9 citations
  Pacritinib combined with sirolimus and low-dose tacrolimus for GVHD prevention after allogeneic hematopoietic cell transplantation: Preclinical and Phase I trial results
  Joseph Pidala, Kelly Walton, Hany Elmariah, Jongphil Kim, Asmita Mishra, Nelli Bejanyan, Taiga Nishihori, Farhad Khimani, Lia Perez, Rawan Faramand, Marco L. Davila, M...> ;Clinical Cancer Research. 2021 Mar 22
• 20 citations
  A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation
  Nelli Bejanyan, Joseph Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faram...> ;Blood Advances. 2021 Mar 9
• 12 citations
  Impact of infused CD34+ stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide.
  Hany Elmariah, Syeda Mahrukh Hussnain Naqvi, Jongphil Kim, Taiga Nishihori, Asmita Mishra, Lia Perez, Rawan Faramand, Aleksandr Lazaryan, Hien D. Liu, Farhad Khimani, ...> ;Bone Marrow Transplantation. 2021 Mar 3
• Join now to see all

Abstracts/Posters

• Impact of TP53 gene Mutation Clearance and Conditioning Intensity on Outcome in MDS or AML Patients Prior to Allogeneic Stem Cell Transplantation
  Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Clearance of Somatic Gene Mutations in Patients with Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) Predicts Outcome
  Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...
  Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Impact of TBI-Based Conditioning Regimen on Outcomes of Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplant: Systematic Revi...
  Hany Elmariah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• CD34+ Cell Dose Influences Survival after Allogeneic Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019